GSK boss Emma Walmsley bows out as HIV and cancer drugs supercharge sales

Daily Mail 1 min read 5 hours ago

GSK lifted profit expectations for the year after the pharma group's sales were boosted by bumper demand for HIV and cancer drugs in the third quarter.
Read original Daily Mail